AGP Executive Report
Last update: 8 hours agoBiotech Funding in Italy: Milan-based Aptadir Therapeutics just closed a €40M seed round led by 4BIO Capital to advance RNA inhibitor therapies, starting with CAP1-FMR1 for Fragile X Syndrome—another big signal for early-stage life sciences in Italy. Startup Finance & DeepTech: Eureka! Venture launched Eureka! Fund II – Deep Tech Lazio, a €20M early-stage fund backed by Lazio Innova (anchor €16M), aiming to pull more private capital into Italian deep tech. Restructuring Support for SMBs: FTI Consulting appointed new turnaround leaders in Milan to help Italian companies and creditors with complex restructurings, reflecting ongoing pressure from costs and weak growth. EU Trade Compliance Pressure: A warning for exporters: even if tariffs fall under an India-EU deal, micro, small and medium firms will still need to meet dense EU rules on sustainability, certification, and supply-chain transparency. Local Business Reality Check: A family-run Italian restaurant in Ireland (Cibo) is closing after rising costs and shrinking margins—an example of the squeeze hitting hospitality operators.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
